Evaluation of phage-antibiotic combinations in the inactivation of urinary tract infection-related bacteria
Abstract
AIMS
To evaluate the efficacy of bacteriophage-antibiotic combination therapy against major urinary tract infection (UTI) pathogens and determine whether combining phages with ciprofloxacin enhances bacterial killing, delays resistance emergence, and improves treatment performance under physiologically relevant conditions.
MATERIALS AND METHODS
Five clinically relevant UTI pathogens were tested: Escherichia coli (UPEC), Enterococcus faecalis, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Proteus mirabilis. Phages from a commercially available cocktail were screened and supplemented with a lab-isolated phage to improve E. coli coverage. In vitro assays evaluated bacterial inactivation using phages alone and in combination with ciprofloxacin at varying concentrations, including sub-MIC levels. Resistance emergence and associated fitness costs were assessed. Ex vivo efficacy was further tested using filtered human urine to simulate physiologically relevant conditions.
RESULTS
Phage-antibiotic combinations significantly enhanced bacterial inactivation across all tested species compared to monotherapies, including at sub-MIC ciprofloxacin concentrations. Combination treatments delayed resistance development and imposed fitness costs on resistant E. coli mutants. Ex vivo urine assays confirmed that phages remained effective in physiologically relevant conditions, particularly in combination regimens, despite reduced antibiotic efficacy in urine.
CONCLUSIONS
Phage-antibiotic…
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.